Cargando…

Low-carbohydrate diets containing plant-derived fat but not animal-derived fat ameliorate heart failure

Cardiovascular disease (CVD) is a global health burden in the world. Although low-carbohydrate diets (LCDs) have beneficial effects on CVD risk, their preventive effects remain elusive. We investigated whether LCDs ameliorate heart failure (HF) using a murine model of pressure overload. LCD with pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Bujo, Satoshi, Toko, Haruhiro, Ito, Kaoru, Koyama, Satoshi, Ishizuka, Masato, Umei, Masahiko, Yanagisawa-Murakami, Haruka, Guo, Jiaxi, Zhai, Bowen, Zhao, Chunxia, Kishikawa, Risa, Takeda, Norifumi, Tsushima, Kensuke, Ikeda, Yuichi, Takimoto, Eiki, Morita, Hiroyuki, Harada, Mutsuo, Komuro, Issei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998649/
https://www.ncbi.nlm.nih.gov/pubmed/36894670
http://dx.doi.org/10.1038/s41598-023-30821-7
Descripción
Sumario:Cardiovascular disease (CVD) is a global health burden in the world. Although low-carbohydrate diets (LCDs) have beneficial effects on CVD risk, their preventive effects remain elusive. We investigated whether LCDs ameliorate heart failure (HF) using a murine model of pressure overload. LCD with plant-derived fat (LCD-P) ameliorated HF progression, whereas LCD with animal-derived fat (LCD-A) aggravated inflammation and cardiac dysfunction. In the hearts of LCD-P-fed mice but not LCD-A, fatty acid oxidation-related genes were highly expressed, and peroxisome proliferator-activated receptor α (PPARα), which regulates lipid metabolism and inflammation, was activated. Loss- and gain-of-function experiments indicated the critical roles of PPARα in preventing HF progression. Stearic acid, which was more abundant in the serum and heart of LCD-P-fed mice, activated PPARα in cultured cardiomyocytes. We highlight the importance of fat sources substituted for reduced carbohydrates in LCDs and suggest that the LCD-P-stearic acid-PPARα pathway as a therapeutic target for HF.